Clin2
NCT07331935Possibly a fitRecruiting

Topical Coenzyme Q10 and Curcumin for Oral Leukoplakia

Oral Leukoplakia

Treatments studied

Part of Cancer, Mouth & dental clinical trials.

This study tests whether a cream containing coenzyme Q10 and curcumin can help treat a common mouth condition called oral leukoplakia (a white patch that can sometimes turn into cancer). It is for people with a specific type of white patch that is not severe and can be easily reached with a cream.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
34 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You must have a white patch inside your mouth (called oral leukoplakia) that is not cancerous or severely abnormal.
  • The lesion must be in a spot where a cream can be applied directly.
  • You cannot have taken any antioxidant supplements like coenzyme Q10, curcumin, or vitamin E in the last 4 weeks.
  • You must not be pregnant or breastfeeding.
  • You must agree to follow the study schedule and return for check-ups.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07387900Recruiting· Phase 2
Metformin for preventing cancer in oral leukoplakia

This study tests if metformin — a medication commonly used for diabetes — can prevent oral leukoplakia from turning into cancer when applied as a mouth rinse and taken as a pill. It is for people with non-severe white patches in the mouth.

Cairo
NCT07453472Not yet recruiting· Phase 3
Light therapy vs. vitamin D cream for mouth white patches

This study tests whether a light-based treatment (photodynamic therapy) works better than a vitamin D cream (calcipotriol) for treating white patches in the mouth that could become cancer. Both treatments are applied directly to the patch.

New Delhi, National Capital Territory of Delhi
NCT03975322Recruiting
Predict which oral white patches may turn cancerous

This study looks at oral leukoplakia (persistent white patches in the mouth) to better predict which ones may develop into cancer. It uses a test based on specific immune and cancer-related markers to help estimate each person’s risk.

Erlangen
NCT05727761Recruiting· Phase 2
Pioglitazone plus metformin for high-risk mouth lesions

This trial studies whether a two-medicine diabetes drug combination can reduce or control risky early changes in certain mouth and throat lesions. You may be asked for small tissue samples (biopsies) before and after 12 weeks to see how the lesions respond.

Minneapolis, Minnesota
NCT06876038Not yet recruiting· Phase 2
Light therapy for early mouth cancer or precancerous spots

This trial tests a low-cost approach to find and treat early mouth cancers or precancerous spots using a special light-activated drug (photodynamic therapy). The goal is to destroy the abnormal cells while sparing healthy tissue.

Ernākulam, Kerala
NCT06932848Recruiting
Curcumin gel for treating oral lichen planus

This trial tests if a curcumin nanogel can help heal painful sores from oral lichen planus compared to a standard corticosteroid gel. If you have this condition, you may be able to join.

Bangkok

Hear when a new Oral Leukoplakia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.